Status:
COMPLETED
Impact on UVB Narrow Band and UVA1 Therapy on Serum 25-hydroxyvitamin D Levels
Lead Sponsor:
University of Zurich
Conditions:
Skin Disease
Eligibility:
All Genders
18+ years
Brief Summary
We plan to investigate the serum elevation of 25(OH)D under UVB nb and UVA1 therapy, in order to determine the effect of these nowadays frequently used wavelengths for phototherapy on vitamin D plasma...
Detailed Description
This is an open observational study in dermatological patients undergoing phototherapy. In patients with a skin disease and the routinely given indication for a phototherapy with UVB narrow-band (UVB...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Dermatological indication for a phototherapy with UVB nb or UVA1
- Oral and written informed patient consent
- Exclusion criteria:
- Interruption of the light therapy for more than 14 days
- Withdrawal of consent to participate
Exclusion
Key Trial Info
Start Date :
March 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
116 Patients enrolled
Trial Details
Trial ID
NCT00910260
Start Date
March 1 2009
End Date
February 1 2011
Last Update
May 20 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dermatology Department, University Hospital
Zurich, Switzerland, 8091